Assessing the Mechanism of Action of “Fructus Ligustri Lucidi-Cuscutae Semen” in Prostate Cancer Treatment Using Network Pharmacology and Molecular Docking

Figure 8

Molecular docking results of potential active components and targets for the treatment of PCa in “Ligustrum lucidum-Cuscutae Semen.” (a) stands of taxifolin and TP53; (b) stands of quercetin and TP53; (c) stands of sesamin and TP53; (d) stands of beta-sitosterol and EGFR; (e) stands of kaempferol and TP53; (f) stands of beta-sitosterol and ESR1.

(a)

(b)

(c)

(d)

(e)

(f)